Even before the legal-marijuana market has begun to simmer, it is easy to spot companies that have potentially strong niches. The following three marijuana stocks are far different in what they have to offer, but their products all share three important qualities: (1) they’re practical, (2) they’re profitable and (3) there is a growing demand for them. Here’s number one company, with a niche that could grow quite rapidly as medical-marijuana continues to get approved state by state throughout the country. Prime Locations Hollywood, Calif.-based Medbox, Inc. (OTCPINK Markets: MDBX), a maker of patented, self-service, identity-verifying medicine dispensers, believes it is perfectly positioned to cash in on the burgeoning medical marijuana market in California. “Legal marijuana is one of the most rapidly expanding medical markets in the U.S., projected to exceed $3 billion in 2014,” said Dr. Bruce Bedrick, chief executive officer, Medbox, Inc., in a written statement. “This rapid growth is creating significant opportunities and Medbox is positioned as the first mover and clear industry leader in this burgeoning sector. Our offerings include sophisticated and comprehensive consulting services for dispensary permit applicants and cultivators, as well as offering dispensing technologies and vaporizers. The breadth and depth of our offerings position us to strengthen our leadership role and we felt it was an appropriate time to retain proven IR counsel to help us raise our visibility in the investment community, communicate our investment thesis and broaden our shareholder base,” he added. Medbox’s dispensers even have the precaution of requiring a finger print check for identity. The company hopes to ultimately place these dispensers in the thousands of clinics and approved facilities that it hopes one day will dispense medical marijuana. New Patents AwardedAt the same time, Medbox is developing and patenting even more practical products for the cannabis industry.
On Jan. 21, Medbox announced that it has expanded its intellectual property portfolio with the confirmation that it has been awarded two additional patents for its Vaporfection brand of products. The announcement was made in conjunction with a comprehensive shareholder update, and Form 10 filing with the Securities and Exchange Commission.
The patents, awarded to the company’s wholly owned subsidiary, Vaporfection International, Inc., specifically relate to:
Vapor Glass™ technology, which features the use of laboratory grade glass encased heating element positioned in the center of the laboratory grade glass heating chamber air pathway. This unique Glass on Glass design results in a superior quality and efficient air/heat flow vapor, which ensures that nothing but the purest convection heated air enters the plant material, which releases the purest, naturally flavored and virtually odorless vapor into the users’ respiratory system. This method is unlike most vaporizers that apply conduction heat to the plant material using ceramics, metals and other possible contaminates in the air pathway.· Vapor Sense™ technology, which features a touch screen interface linked to an automatic temperature sensing control system. The technology uses a digital microprocessor temperature controller directly connected to a thermo coupling temperature sensor in the heating chamber. It also incorporates a fixed temperature setting option, auto shut-off, and cool-down safety features.
MDBX share price closed at $31.80 on Jan. 31, down $2.35 from its closing price of $34.15 the previous day.Find out what could be the best investor’s move when it comes to MDBX by getting the complete report here, or by cutting and pasting the following link in your Web browser:
http://www.sixfigurestockpicks.com
Number two company is close to making a breakthrough in licensing and is poised to cash in on the mass distribution of medical marijuana from its warehouse in Canada.
Moving toward Canadian Approval
Health Canada forecasts that there will be half a million medical marijuana users in Canada in 10 years, but Creative Edge Nutrition Inc.’s (OTC Pink: FITX) CEO Bill Chaaban told Forbes Magazine Dec. 30 that with the availability and the assurance of consistency of the product it could only take two years for users to reach that magnitude.
A Potential Windfall – Operative Word ‘Potential’
These forecasts point toward a potential windfall for Creative Edge and other companies like them, if the Canadian government grants the Michigan-based company the final approval to sell medical marijuana in the country.
On Jan. 9, Creative Edge inched closer to approval by complying with the Canadian government’s regulations on tracking 1.3 million pounds of medical marijuana annually. The medical marijuana is to be distributed by Creative Edge’s wholly owned subsidiary CEN Biotech.
Creative Edge cleared this obstacle by using a new state-of-the-art M3Hub Seed-to-Sale tracking platform, which meets and exceeds Health Canada’s tracking compliance regulations. This news comes less than two months after Creative Edge broke ground on its new 58,000-square-foot future Medical Marijuana distribution center, which will be attached to the company’s current 26,400-square-foot facility.
Find out what could be the best investor’s move when it comes to FITX by getting the complete report here, or by cutting and pasting the following link in your Web browser:
http://www.sixfigurestockpicks.comIn November, the company was notified by Canada’s federal health department, Health Canada, that it has been issued permission to build its cannabis facility. Upon completion it will be inspected by Health Canada for a permit to begin operation.
If all goes well, it will be an historic moment for Creative Edge; however, if the approval runs into trouble, it would be a major setback for the company.
At close of the market on Feb. 5, 2014 FITX share price closed at 6 cents, up 1 cent from 5 cents a share the previous day.
Find out what could be the best investor’s move when it comes to FITX by getting the complete report here, or by cutting and pasting the following link in your Web browser:
http://www.sixfigurestockpicks.com Number three company’s niche combines cannabis with beauty, health products and in-home selling. Distributor Found for Cannabis Anti-Aging CreamOn Feb. 5, Medical Marijuana Inc. (OTC PINK: MJNA) share volume continued to soar, with 35,033,421 shares changing hands, significantly higher than its 3-month average of 22,691,206 shares. The continuing surge in volume was probably triggered by a Jan. 31 announcement made by the San Diego holding company that it had entered into an agreement with an unnamed company to sell Medial Marijuana’s anti-aging cream through the unnamed company’s in-home sales force. According to the release, the first purchase order from the home-based business organization will be $1,072,251 in products that will ship before the end of the first quarter.”This positive news come on the only two days after Medical Marijuana announced its newly-formed subsidiaries would be providing armored transport services for companies in the cannabis industry. Marijuana Inc.’s subsidiary, Wellness Managed Services, has gained this capability by purchasing a 50% stake in MPS International. Cannabis Security Issue In a written statement, MPS International’s CEO Mike Roberts outlined some specifics about the new armored marijuana transport service. “Large amounts of product will be moved from grow to wholesaler, warehouse, testing facilities, bakeries, infusion laboratories and finally to retail locations,” Roberts said. “Post transaction, and especially right now with federal regulations prohibiting FDIC insured banks from offering financial services to cannabis industry businesses, large amounts of cash will need to be transported between parties securely as this creates an easy target for predators and competing businesses,” he added. Potentially Lucrative Opportunity In the release, Roberts went on to outline the potential opportunity that existed for providing armor transportation for currently legal cannabis businesses. He pointed out that there are now about 448 dispensaries in Colorado alone, while in California there are an estimated 2,700 dispensaries, co-operatives, wellness clinics, and taxi delivery services. “Using an average of one armed security officer working 10 hour shifts, 7 days per week billing at the industry standard of $25/hour armed, 52 weeks per year, annual gross revenue created by just 11 locations is more than $1,000,000 for just static physical security,” Roberts explained. Once the company establishes this footprint, it says it will evaluate other cannabis markets such as those in Canada. MJNA share price closed at 35 cents, up 4 cents from its closing price of 31 cents the previous day.Find out what could be the best investor’s move when it comes to MJNA by getting the complete report here, or by cutting and pasting the following link in your Web browser:
http://www.sixfigurestockpicks.com
ABOUT US:
Sixfigurestockpicks.com issues momentum alerts on stocks that can provide gains to day traders.
Sixfigurestockpicks.com provides members with timely information and exclusive alerts on cheap and under-valued stocks in the United States with the potential to deliver gains of 100% – 200% or more.
Sixfigurestockpicks.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals DailyStockMotion.com is often in the know of several large investor awareness campaigns being deployed.
Timing is everything when trading Penny Stocks. Gain an Edge by joining the Sixfigurestockpicks.com newsletter and receiving alerts from a Pro-Active team of researchers. Trading Alerts believes traders should have a chance at successfully trading penny stocks and invites traders and investors to be part of the Free VIP membership.
Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www.sixfigurestockpicks.com
Disclosure
Sixfigurestockpicks.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always own due diligence with any potential investment.
